))
#015 - Decoding the Science and Strategy of Hemp Derived Cannabinoids w/ Dave Neundorfer
Manage episode 381036298 series 3509840
Το περιεχόμενο παρέχεται από το AnnaRae Grabstein and Ben Larson, AnnaRae Grabstein, and Ben Larson. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον AnnaRae Grabstein and Ben Larson, AnnaRae Grabstein, and Ben Larson ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Are you ready to embark on a thrilling journey through the intricate world of hemp-derived cannabinoids? This episode promises a deep dive with Dave Neundorfer, the CEO of Open Book Extracts who has an intriguing tale to tell; from co-founding a leading Ohio medical marijuana company to leading his current venture. Open Book Extracts is a unique ingredient manufacturer and product development house focusing on cannabinoid-enabled health and wellness. Dave reveals how the company traversed through a rapidly evolving customer base and navigated regulatory challenges to offer a transparent and reliable industry presence.
The hemp industry is an exciting yet complex landscape. This episode will clue you in on the regulatory dynamics and the significant strides made in the collaborative process outlined by the FDA. There's a lot to chew on here, from discussions on the One Hemp coalition - a unified voice of responsible operators in the space - to finding a compromise that will set a bar for regulation that is palatable to the FDA. It's a must-listen for anyone curious about the regulatory aspects of the hemp industry and the importance of a unified industry stance.
But that's not all; we get to the heart of intellectual property development around minor cannabinoids. Open Book Extracts has been on this research journey since 2019, and Dave shares some of the fascinating insights they've unearthed. We also discuss their strategic business decisions, including the pursuit of EU GNP certification and the role equity capital has played in their growth. Plus, we delve into the current state of the cannabis and hemp markets, supply contract changes, and a call to action for industry support and progress. Prepare to be enlightened, entertained, and inspired!
--
High Spirits is brought to you by Vertosa and Wolf Meyer.
Your hosts are Ben Larson and AnnaRae Grabstein.
Follow High Spirits on LinkedIn.
We'd love to hear your thoughts. Who would you like to see on the show? What topics would you like to have us cover?
Visit our website www.highspirits.media and listen to all of our past shows.
THANK YOU to our audience. Your engagement encourages us to keep bringing you these thought-provoking conversations.
Remember to always stay curious, stay informed, and most importantly, keep your spirits high.
Κεφάλαια
1. #015 - Decoding the Science and Strategy of Hemp Derived Cannabinoids w/ Dave Neundorfer (00:00:00)
2. Exploring Hemp-Derived Cannabinoids and Industry (00:00:01)
3. OpenBook Extracts (00:06:00)
4. Hemp Industry Regulatory Clarity and Unity (00:12:11)
5. Exploring Minor Cannabinoids and IP Development (00:30:12)
6. Cannabis Market Supply Chain Contracts (00:44:02)
58 επεισόδια
Μοίρασέ το
